Literature DB >> 19483318

The alleviating pain effect of aqueous extract from tong-xie-yao-fang, on experimental visceral hypersensitivity and its mechanism.

Xu-Guang Hu1, Di Xu, Yue Zhao, Xiang-Bo Yang, Jiang Meng, Han Shen, Jiao Guo.   

Abstract

Tong-Xie-Yao-Fang (TXYF) is a prescription in traditional chinese medicine (TCM), used for relieving abdominal pain associated with irritable bowel syndrome. The aim of the present study was to investigate the effects and mechanism of TXYF on experimental visceral hypersensitivity (VH) models. TXYF affected the abdominal withdrawal reflex produced by colonic distention in maternal separation-induced visceral hypersensitivity rats, in a dosage-dependent manner. TXYF significantly decreased serotonin (5-HT) levels in serum and corticotrophin releasing factor (CRF) concentrations in the brain. Moreover, it was found that VH alleviation by TXYF was dependent on the substance P (SP) expression in the colon mucosa. These results suggest that TXYF attenuates behavioral hyperalgesia by regulating substance associated with the brain-gut axis, including decreasing the expression of 5-HT and SP in the periphery and that of CRF in the center.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483318     DOI: 10.1248/bpb.32.1075

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

Review 1.  Herbal medicines for the management of irritable bowel syndrome: a comprehensive review.

Authors:  Roja Rahimi; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

2.  Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.

Authors:  Hai-Lian Shi; Chu-Hsuan Liu; Li-Li Ding; Yu Zheng; Xiao-Yan Fei; Lu Lu; Xue-Ming Zhou; Jian-Ye Yuan; Jian-Qun Xie
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.

Authors:  Feng-yun Wang; Min Su; Yong-qiu Zheng; Xiao-ge Wang; Nan Kang; Ting Chen; En-lin Zhu; Zhao-xiang Bian; Xu-dong Tang
Journal:  Acta Pharmacol Sin       Date:  2015-05-11       Impact factor: 6.150

Review 4.  Chinese Herbal Medicine for Functional Abdominal Pain Syndrome: From Clinical Findings to Basic Understandings.

Authors:  Tao Liu; Ning Wang; Li Zhang; Linda Zhong
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629

5.  The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats.

Authors:  Xiangxue Ma; Xiaoge Wang; Nan Kang; Ting Chen; Haijie Ji; Lin Lv; Xiaolan Yin; Yaxin Tian; Rui Zheng; Yuanzhi Duan; Fengyun Wang; Xudong Tang
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-26       Impact factor: 2.629

6.  Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis.

Authors:  Yi-Lin Li; Cheng-Jiao Yao; Rong Lei; Fengjiao Xie; Qin Xiong; Li-Hong Luo; Pei-Min Feng
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

7.  The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor.

Authors:  Xuguang Hu; Xiaojun Zhang; Bin Han; Weijian Bei
Journal:  BMC Complement Altern Med       Date:  2013-10-02       Impact factor: 3.659

8.  Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang.

Authors:  Guanqun Chao; Yingying Wang; Fangxu Ye; Shuo Zhang
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

9.  The efficacy of the traditional Korean herbal medicine Tongsayobang for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.

Authors:  Gajin Han; Seok-Jae Ko; Keumji Kim; Hyejin Jun; Jae-Woo Park
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.